The Russian President announced on Tuesday that he is approving a Covid-19 vaccine developed in Russia, and he is claiming that it is the world’s first vaccine to be approved for use. This announcement comes with unanswered questions and concerns from worldwide health authorities about its effectiveness and safety.
Putin stated on Russian television that the vaccine has been registered as the first such treatment in the world on Tuesday morning. He stated that he was sure of its effectiveness and safety. As evidence for this claim, he announced that his daughter had taken the vaccine with only minor side effects. Putin claimed that the Russian vaccine provides a stable immunity.
The Russian vaccine was developed by the Gamaleya Institute located in Moscow. The institute named the vaccine Sputnik-V, which is a reference to the Russian satellite that enabled Russia to take an initial lead during the space race of the 1950s. Like this vaccine, the Sputnik launch was a surprise to the world that shed new light on Russia’s capacity to develop technology.
Despite this surprise announcement by the Russian president, the Sputnik-V vaccine still has to go through phase 3 trials before it can be administered to the population at large. This claim of victory by the Russian president raises some well-deserved suspicions that the vaccine development process must have cut some important corners in order to pull ahead of other nations’ efforts.
Political analysts have stated that the Kremlin has placed political pressure on medical researchers to portray Russian as the leader in the race to combat the global pandemic. There is no current data available from Russian researchers that verify the claims that the vaccine is effective or safe.
Russian authorities have also claimed that a number of governments and U.S. companies have voiced interests in obtaining the vaccine. The leader of the vaccine development team, Kirill Dmitriev, stated on Monday that a total of 1 billion doses of the vaccine have been requested by a number of countries.
Dmitriev announced that Russia is currently capable of producing 500 million doses of the vaccine per year, and plans are underway to increase the production capacity to a greater level. The countries that have shown the most interest in the Russian vaccine are located in Latin America, the Middle East and Asia. The researcher also stated that phase 3 trials would begin on Wednesday, and people would be tested with the vaccine in Russian and a number of other nations.
The Professor of Immunology at Imperial College London, Danny Altmann, has informed reporters that a premature release of a vaccine without rigorous testing protocols could cause a great deal of damage to people and to the fight against the pandemic. He stated that the criteria for deeming a vaccine safe for general use are very stringent. He summed up his comments by saying that all medical researchers throughout the world are in this fight together.
Russian authorities have denied any concerns about the safety of the vaccine. The Russian Health Minister has claimed that many people were tested with the vaccine, and none of them suffered severe complications. He also explained that the participants in the study produced high enough amounts of antibodies to enable them to resist the virus.
The Coronavirus has currently infected more than 20 million people throughout the world, and more than 730,000 people have died from the disease. Twenty-five vaccines are currently being evaluated by researchers in various nations. Vaccine research at Oxford and the US National Institute of Health are both showing promising results as they undergo Phase 3 testing of large groups of participants.